Thursday, June 18, 2026 · Rahul Mittal
Pharmaceutical product launches often miss revenue targets not because of poor forecasting or limited capacity, but because organizations lack the execution infrastructure needed to make fast, prioritized supply allocation decisions when market conditions change.
Monday, April 27, 2026 · Brian Straight
One year after its rebrand, Infios is shifting from identity-building to execution, as rising demand, pragmatic AI adoption, and a focus on speed to value redefine how companies invest in supply chain technology.